Influence of substituted tetrahydroisoquinolines and catecholamines on lipolysis, in vitro. II. Stereoselectivity.
D000273:Adipose Tissue / Q000378:metabolism*; D000818:Animals; D004336:Drug Antagonism; D005990:Glycerol / Q000378:metabolism*; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000008:administration & dosage / Q000494:pharmacology*; D007546:Isoquinolines / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D050356:Lipid Metabolism; D008297:Male; D009638:Norepinephrine / Q000008:administration & dosage / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D013237:Stereoisomerism; D013268:Stimulation, Chemical; D013329:Structure-Activity Relationship
D007546:Isoquinolines; D011433:Propranolol; D007545:Isoproterenol; D005990:Glycerol; D009638:Norepinephrine; D010646:Phentolamine